The impact of food and drug administration-based eligibility criteria on demographic representation in current phase III clinical trials for newly diagnosed breast cancer.
Authors: Tanvee Varma, Lauren Merz, Yating Wang, Angel Cronin, Rachel A. Freedman, Gregory A. Abel, Andrew Hantel